KCNA1 expression and site specific DNA methylation in thyroid cancer

Background KCNA1 encodes the voltage-gated potassium channel Kv1.1 and has been implicated in thyroid cancer. Its relationship with DNA methylation and tissue composition remains incompletely understood. Methods TCGA-THCA expression profiles from 505 primary tumors and 59 normal samples and methylation profiles from 507 tumors and 56 normal samples were analyzed using limma. KCNA1 expression was assessed in GSE33630, TPC-1 cells, and xenograft tissues. Clinical associations, receiver operating characteristic curves, CpG-specific methylation, functional enrichment, and immune signatures were examined. ESTIMATE-based stratification and thyroid differentiation scores were used to assess tissue composition, and CpG-expression associations were tested within tumors with and without purity adjustment. Results The analysis identified 2,538 differentially expressed genes and 15,261 differentially methylated probes. KCNA1 expression was lower in TCGA tumors (log2FC = -4.680; adjusted P = 1.73 × 10 -67 ), whereas the difference in GSE33630 was not significant (log2FC = -0.0736; adjusted P = 0.108). Lower expression was also observed in TPC-1 cells and xenograft tissues. Within TCGA tumors, KCNA1 correlated negatively with the ESTIMATE-derived purity score (rho = -0.263) and positively with thyroid differentiation (rho = 0.356). Expression remained lower than normal thyroid in the highest purity quartile (P = 1.67 × 10 -25 ). Among 25 KCNA1 CpGs, the hypomethylated 3′UTR site cg22669120 correlated positively with expression. Inverse associations at cg06204922 and cg20392607 were no longer significant after purity adjustment and correction for multiple testing. Conclusion KCNA1 downregulation in TCGA-THCA is accompanied by heterogeneous CpG-specific methylation patterns and variation in tissue composition. The nonsignificant external expression result and attenuation of promoter-related associations indicate that the relationship between KCNA1 methylation and expression requires further investigation.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-20
DOI
https://doi.org/10.3389/fonc.2026.1994182
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

KCNA1 expression and site specific DNA methylation in thyroid cancer

Li Lv, Chengfei Wang, Yangbo Kang, Qi Yang et al.
Frontiers in Oncology
Thyroid Cancer Diagnosis and Treatment
article

KCNA1 expression and site specific DNA methylation in thyroid cancer

Li Lv, Chengfei Wang, Yangbo Kang, Qi Yang, Yunyi Ding, Xiaoying Chen, Yongan Xu, Xu Wang, Li Hong
article en

Abstract

Background KCNA1 encodes the voltage-gated potassium channel Kv1.1 and has been implicated in thyroid cancer. Its relationship with DNA methylation and tissue composition remains incompletely understood. Methods TCGA-THCA expression profiles from 505 primary tumors and 59 normal samples and methylation profiles from 507 tumors and 56 normal samples were analyzed using limma. KCNA1 expression was assessed in GSE33630, TPC-1 cells, and xenograft tissues. Clinical associations, receiver operating characteristic curves, CpG-specific methylation, functional enrichment, and immune signatures were examined. ESTIMATE-based stratification and thyroid differentiation scores were used to assess tissue composition, and CpG-expression associations were tested within tumors with and without purity adjustment. Results The analysis identified 2,538 differentially expressed genes and 15,261 differentially methylated probes. KCNA1 expression was lower in TCGA tumors (log2FC = -4.680; adjusted P = 1.73 × 10 -67 ), whereas the difference in GSE33630 was not significant (log2FC = -0.0736; adjusted P = 0.108). Lower expression was also observed in TPC-1 cells and xenograft tissues. Within TCGA tumors, KCNA1 correlated negatively with the ESTIMATE-derived purity score (rho = -0.263) and positively with thyroid differentiation (rho = 0.356). Expression remained lower than normal thyroid in the highest purity quartile (P = 1.67 × 10 -25 ). Among 25 KCNA1 CpGs, the hypomethylated 3′UTR site cg22669120 correlated positively with expression. Inverse associations at cg06204922 and cg20392607 were no longer significant after purity adjustment and correction for multiple testing. Conclusion KCNA1 downregulation in TCGA-THCA is accompanied by heterogeneous CpG-specific methylation patterns and variation in tissue composition. The nonsignificant external expression result and attenuation of promoter-related associations indicate that the relationship between KCNA1 methylation and expression requires further investigation.

Frontiers in OncologyVol. 16
Guizhou University of Traditional Chinese Medicine (CN), Second Affiliated Hospital of Zhejiang University (CN), Zhejiang University (CN)
Good health and well-being
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon